Serum TGM2 levels were significantly higher in HCC patients and positively correlated with the histological grade and tumor size (135), indicating that TGM2 may be a useful histological and serologic candidate biomarker for ANHC diagnosis, although more studies are required to confirm the value of TGM2 in ANHC diagnosis. This evidence concerns the gene TGM2 and neoplasm.